Better Adherence to Therapeutic Lifestyle Change Efforts Trial



Status:Completed
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/19/2016
Start Date:November 2007
End Date:April 2011

Use our guide to learn which trials are right for you!

Better Adherence to Therapeutic Lifestyle Change Efforts (BATTLE) Trial

The purpose of this study is to determine whether knowledge of abnormal results from a
noninvasive test for detection of subclinical atherosclerosis (carotid intima media
thickness [CIMT]), in addition to knowledge of cardiovascular disease (CVD) risk factors,
enhances adherence to healthy lifestyle behaviors in comparison to only CVD risk factor
knowledge. We believe that participants with CVD risk factors who have knowledge of their
own CIMT test results showing significant subclinical atherosclerosis will demonstrate
better adherence to therapeutic lifestyle change (TLC) than those subjects from whom the
CIMT test information is withheld.

The outcomes of subjects randomized to receive their CIMT information (R-CIMT Group) will be
compared to a control condition of subjects randomized to have their CIMT information
withheld (W-CIMT Group) until the completion of a lifestyle intervention that is common to
both groups. The rationale for this intervention is based on the Health Belief Model theory
that risk awareness prompts action for behavioral change. In particular, our aim is to study
the impact of a subject's own CIMT results, and not the impact of generic educational
material related to CIMT and CHD risk, on adherence to a lifestyle change program. Subjects
will not know the hypothesis of this study because this knowledge could potentially impact
their behavior during the intervention. Also, subjects will not be told that only half of
them will receive their CIMT information before the lifestyle intervention, since subjects
could potentially infer the study hypothesis from this knowledge. To answer the question of
whether CIMT results would be a useful motivational tool for adherence to lifestyle change
recommendations, there needs to be a comparison group that does not have their CIMT results.
Subjects will be clearly told in the consent process results that they may not receive
results of their clinical testing, including the CIMT results, until the end of their
participation in this study. Randomization will occur after subjects successfully complete a
"run-in" period during screening, which introduces the lifestyle intervention and teaches
the proper use of the data collection tools. At the beginning of each week in the randomized
phase of the study, subjects will receive a confidential packet of scripted materials.
Packets will contain identical information (e.g. educational materials, class schedules,
feedback from diet/exercise logs) except that the R-CIMT group will also receive a report
that contains a copy of one of their own ultrasound scans, with a comparison picture of a
normal scan. This report will also include the CIMT thickness in each artery and an
interpretation that states that their measurements are in the highest quartile for persons
of their age and gender. Attached to the report will be a tutorial ("Interpreting Your CIMT
Results") to more fully educate participants on detection of atherosclerosis with carotid
ultrasound. Both the CIMT results report and the tutorial specifically couple the presence
of significant subclinical atherosclerosis with increased risk for cardiovascular morbidity
and mortality. (Appendix D). If subjects from whom CIMT information is withheld request
their CIMT results during the study, they will be told that those results will be made
available to them at the end of their participation in the study, which is consistent with
the information they were given in the consent process. At the end of the study, subjects
who were randomized to receive their CIMT information will be asked to complete a quiz
(Atherosclerosis and CIMT Knowledge Assessment) to determine their comprehension of the CIMT
information that had been provided to them at randomization (Appendix D).

Lifestyle Intervention

All randomized subjects will participate in a 12-week lifestyle intervention program that
will be introduced and observed in the "run-in" period during screening. This intervention
will incorporate strategies that have proven benefit in reduction of CVD risk including
aerobic exercise, Mediterranean-type diet, and ongoing contact with weekly, on-site group
sessions for lifestyle change education and support integrating Transtheoretical Stages of
Change and Social Cognitive learning theories.74-76 To minimize the potential of unblinding
research staff to the randomization assignment of a large number of subjects, subjects will
enter the next available block of 12-weekly group sessions regardless of randomization
assignment. To minimize the potential of unblinding study subjects to the study hypothesis,
all subjects will be instructed to refrain from discussing any personal medical or
information contained in their weekly packet received during the group support sessions.
Randomization assignment will be known only to statistician/data management team.

Aerobic Exercise Physical activity is a pillar of any lifestyle intervention program because
it improves cardiorespiratory and muscular fitness and promotes improvement of CHD risk
factors including obesity, diabetes, hypertension, and hyperlipidemia. Based on each
subject's baseline fitness and safety issues, a physical activity program (with a goal of
180 minutes of aerobic exercise per week by the end of the study) will be prescribed by an
exercise physiologist and tailored to individual choices from various types of moderate
intensity activities. Exercise is recommended to occur on most days of the week and for at
least 10 minutes per session within a defined target heart rate range. After the "run-in"
period, exercise will be unsupervised but assessed with a heart rate monitoring device and
self-monitoring logs.

Diet A Mediterranean-type diet with caloric goals based on each subject's weight will be
prescribed by a registered dietician. The composition of the diet is structured to encourage
consumption of plant-based, minimally processed, seasonal foods including fruits,
vegetables, whole grains, legumes, nuts, fish and poultry in preference to red meat, low-fat
dairy products, and limited amounts of beneficial unsaturated oils such as olive oil. The
recommended diet will have a maximum of 35% of total calories from fat, a maximum of 7% of
total calories from saturated fat, and a minimum of 15% of total calories from protein.
Subjects will be instructed in meal planning and food preparation. Structured menus will be
offered as an option. Review of self-monitoring logs by the dietician will guide individual
feedback during the "run-in" period and in the weekly communication packets during the
randomized period.

Group Support Weekly on-site sessions will be held to stimulate social support for the
lifestyle intervention. A structured curriculum focusing on goal setting, problem solving,
and stress reduction will be presented by a trained facilitator with opportunity for open
discussion. To reinforce the diet plan, a group meal and periodic food preparation
demonstrations also will occur during these sessions.

Inclusion Criteria:

- Military healthcare beneficiary

- Willing to modify current diet and exercise habits

- Two or more of following CVD risk factors (hypertension, hyperlipidemia, family
history, tobacco use, BMI >/= 25 kg/m2)

- Metabolic syndrome

Exclusion Criteria:

- Clinical CVD or conditions that limit safe participation

- Individuals who participation would interfere with conduct of trial

- No significant preclinical atherosclerosis
We found this trial at
1
site
?
mi
from
Bethesda, MD
Click here to add this to my saved trials